Comparison of the correlation of the Selvester QRS scoring system with cardiac contrast-enhanced magnetic resonance imaging-measured acute myocardial infarct size in patients with and without thrombolytic therapy

Journal of Electrocardiology

Volumn 42, Issue 2, 2009, Pages 139-144

  Rovers, Walther C M ^a   van Boreen, Marit C ^a   Robinson, Madeleine ^b   Martin, Thomas N ^b   Maynard, Charles ^c   Wagner, Galen S ^d   Gorgels, Anton P M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Contrast enhanced magnetic resonance imaging; Selvester QRS score; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; SELVESTER QRS SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; THROMBOLYTIC THERAPY;

EID: 60349107765     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2008.12.004     Document Type: Article

References (28)

1. Heiberg E., Ugander M., Engblom H., et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 246 (2008) 581
2. Choi K., Kim R., Gubernikoff G., Vargas J., Parker M., and Judd R. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 (2001) 1101
3. Engblom H., Arheden H., Foster J.E., and Martin T.N. Myocardial infarct quantification: is magnetic resonance imaging ready to serve as a gold standard for electrocardiography?. JECG 40 (2007) 243
4. Pahlm U.S., Chaitman B.R., Rautaharju P.M., Selvester R.H., Tamesis B.R., and Wagner G.S. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle. AJC 81 (1998) 809
5. Ideker R.E., Wagner G.S., Ruth W.K., et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol 49 (1982) 1604
6. Roark S.F., Ideker R.E., Wagner G.S., et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol 51 (1983) 382
7. Ward R.M., White R.D., Ideker R.E., et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts. Am J Cardiol 53 (1984) 706
8. Sevilla D.C., Wagner N.B., Pegues R., et al. Correlation of the complete version of the Selvester QRS scoring system with quantitative anatomic findings for multiple left ventricular myocardial infarcts. Am J Cardiol 69 (1992) 465
9. Gettes L.S. The status of the standards. J Electrocardiol 42 (2009) xxx
10. Hinohara T., Hindman N.B., White R.D., Ideker R.E., and Wagner G.S. Quantitative QRS criteria for diagnosing and sizing myocardial infarcts. (edit). Am J Cardiol 53 (1984) 875
11. Wagner G.S., Freye C.J., Palmeri S.T., et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement. Circulation 65 (1982) 342
12. Babbitt D., Marcus F., Wagner G.S., and Serokman R. Comparison of a QRS scoring system for estimating acute infarct size with radionuclide left ventriculography. Am Heart J 108 (1984) 1426
13. Horáček B.M., Warren J.W., Albano A., et al. Development of an automated Selvester scoring system for estimating the size of myocardial infarction from the electrocardiogram. JECG 29 (2006) 162
14. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. JACC 36 (2000) 959
15. Macfarlane P. Appendix 1: normal limits. In: Macfarlane P., and Lawrie T. (Eds). Comprehensive electrocardiology. 1st ed (1989), Pergamont Press, New York 1442
16. Perron A., Lim T., Pahlm-Webb U., Wagner G.S., and Pahlm O. Maximal increase in sensitivity with minimal loss of specificity for diagnosis of acute coronary occlusion achieved by sequentially adding leads from the 24-lead electrocardiogram to the orderly sequenced 12-lead electrocardiogram. JECG 40 (2007) 463
17. Martin T.N., Groenning B.A., Murray H.M., et al. ST-segment deviation analysis of the admission 12-lead electrocardiogram as an aid to early diagnosis of acute myocardial infarction with a cardiac magnetic resonance imaging gold standard. JACC 50 (2007) 1021
18. Bayés de Luna A., Wagner G., Birnbaum Y., et al. A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circ 114 (2006) 1755
19. Engblom H., Hedström E., Heiberg E., Wagner G.S., Pahlm O., and Arheden H. Size and transmural extent of first-time reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12-lead ECG. AHJ 150 (2005) 920.e1
20. Fieno D.S., Kim R.J., Chen E.L., et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36 (2000) 1985
21. Engblom H., Wagner G.S., Setser R.M., et al. Development and validation of techniques for quantitative clinical assessment of myocardial infarction in vivo by ECG and MRI. JECG 35 Suppl (2002) 203
22. Kim R.J., Ficno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992
23. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. JACC 44 (2004) 1533
24. Peterson S.E., Mohrs O.K., Horstick G., et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 6 (2004) 541
25. Wagner A., Mahrholdt H., Thomson L., et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. JACC 47 (2006) 2027
26. Oshinski J.N., Yang Z., Jones J.R., Mata J.F., and French B.A. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 104 (2001) 2838
27. Hedstrom E., Arheden H., Eriksson R., Johansson L., Ahlstrom H., and Bjerner T. Importance of perfusion in myocardial viability studies using delayed contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 24 (2006) 77
28. Bang L.E., Ripa R.S., Grande P., Kastrup J., Clemmensen P.M., and Wagner G.S. Comparison of infarct size changes with delayed contrast-enhanced magnetic resonance imaging and electrocardiogram QRS scoring during the 6 months after acutely reperfused myocardial infarction. J Electrocardiol 41 (2008) 609